The companies announced a long-term collaboration to make obesity treatments more affordable, they said on Tuesday.

Eli Lilly LLY-3.25%decrease; red down pointing triangle revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio. The drug maker logged ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...

Novo Nordisk NOVO.B-0.63%decrease; red down pointing triangle shares fell Tuesday after Eli Lilly LLY-1.26%decrease; red down pointing triangle announced results of a new pill that could rival the ...

Novo Nordisk has launched a direct-to-consumer (DTC) option for uninsured or under-insured people wanting to access its GLP-1 agonist weight-loss drug Wegovy ... rival Eli Lilly adopted a similar ...

Despite this, two months on, she is still suffering from dizzy spells and hair loss. Drug firm Eli Lilly ... all the red and yellow [indicating her health statistics such as weight, body mass ...

She consulted her GP and was told her folic acid levels were low and came off the jab in February but is still having dizzy spells and hair loss. Eli Lilly ... a new weight loss drug dubbed ...

Mounjaro and Wegovy are two of the biggest names in the world of weight-loss drugs but it's been unclear which is more ... The research was funded by the Mounjaro's manufacturer Eli Lilly, The ...

This double action makes it particularly effective at supporting weight loss ... pen. The costs of auto-injector pens through LillyDirect start from $25 per month with the Eli Lilly Savings ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...